EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum glycomic profile as a predictive biomarker of recurrence in patients with differentiated thyroid cancer

Matthew R Kudelka, Yi Lasanajak, David F Smith, Xuezheng Song, Mohammad S Hossain, Taofeek K Owonikoko iD

Cancer Medicine · 2023-03 · 12 (6) · 6768-6777

DOI: 10.1002/cam4.5465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 27.11.2022. Verfasst von Matthew R Kudelka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USA. Hauptthemen laut MEDLINE: Adenocarcinoma, Thyroid Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Thyroid cancer recurrence following curative thyroidectomy is associated with increased morbidity and mortality, but current surveillance strategies are inadequate for early detection. Prior studies indicate that tissue glycosylation is altered in thyroid cancer, but the utility of serum glycosylation in thyroid cancer surveillance remains unexplored. We therefore assessed the potential utility of altered serum glycomic profile as a tumor‐specific target for disease surveillance in recurrent thyroid cancer. Experimental design We employed banked serum samples from patients with recurrent thyroid cancer post thyroidectomy and healthy controls. N‐glycans were enzymatically released from serum glycoproteins, labeled via permethylation, and analyzed by MALDI‐TOF mass spectrometry. Global level and specific subtypes of glycan structures were compared between patients and controls.

Results

We evaluated 28 independent samples from 13 patients with cancer recurrence and 15 healthy controls. Global features of glycosylation, including N‐glycan class and terminal glycan modifications were similar between groups, but three of 35 individual glycans showed significant differences. The three glycans were biosynthetically related biantennary core fucosylated N‐glycans that only varied by the degree of galactosylation (G0F, G1F, and G2F; G: galactose, F: fucose). The ratio of G0F:G1F that captures reduced galactosylation was observed in patients samples but not in healthy controls ( p = 0.004) and predicted thyroid cancer recurrence (AUC = 0.82, CI 95% = 0.64–0.99).

Conclusions

Altered N‐glycomic profile was associated with thyroid cancer recurrence. This serum‐based biomarker would be useful as an effective surveillance tool to improve the care and prognosis of thyroid cancer after prospective validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaThyroid NeoplasmsHumansGlycomicsNeoplasm Recurrence, LocalBiomarkersPolysaccharidesSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Stichwörter der Autor:innen

Glycomebiomarkerglycanprofilingrecurrencethyroid cancer

Substanzen

BiomarkersPolysaccharides

Autor:innen und Institutionen

  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Hematology and Medical Oncology, Emory University Winship Cancer Institute, Atlanta, Georgia, USA.

ORCID-Profile: Taofeek K Owonikoko

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS
  • National Cancer Institute

Zitieren

APA

Kudelka, M. R., Lasanajak, Y., Smith, D. F., Song, X., Hossain, M. S., & Owonikoko, T. K. (2023). Serum glycomic profile as a predictive biomarker of recurrence in patients with differentiated thyroid cancer. Cancer Medicine, 12(6), 6768-6777. https://doi.org/10.1002/cam4.5465

Vancouver

Kudelka MR, Lasanajak Y, Smith DF, Song X, Hossain MS, Owonikoko TK. Serum glycomic profile as a predictive biomarker of recurrence in patients with differentiated thyroid cancer. Cancer Medicine. 2023;12(6):6768-6777. doi:10.1002/cam4.5465

BibTeX
@article{Kudelka2023,
  author = {Kudelka, Matthew R and Lasanajak, Yi and Smith, David F and Song, Xuezheng and Hossain, Mohammad S and Owonikoko, Taofeek K},
  title = {Serum glycomic profile as a predictive biomarker of recurrence in patients with differentiated thyroid cancer},
  journal = {Cancer Medicine},
  year = {2023},
  volume = {12},
  number = {6},
  pages = {6768--6777},
  doi = {10.1002/cam4.5465}
}
Kostenlos starten →